3 ms·
Whenever i see nano particles used to combat disease, I am always interested in the off target controls. Since they are using physical mechanism to disrupt memb
by danielmorozoff 10y ago
Whenever i see nano particles used to combat disease, I am always interested in the off target controls. Since they are using physical mechanism to disrupt membrane stability (in the case of bacteria), controlling targeting is very difficult and requires vastly different membrane properties on the surface of bacteria vs regular cells. Issues usually involve lodging of nano particles in the liver or kidneys/ lysis and cytotoxicity . Here they looked at haemolytic and necrotic activities in cells and assessed whether the mice survived- most are short term, and aggregation of nano particles is not uncommon to cause large obvious pathology, it just takes time.
I looked up the core molecule 'PAMAM' or Poly(amidoamine) and it seems to show relatively low cytoxicity, but recent studies seem to shed some more light:
'More recently, a series of studies by Mukherjee et al.[13][14][15] have shed some light on the mechanism of PAMAM cytotoxicity, providing evidence that the dendrimers break free of their encapsulating membrane (endosome) after being absorbed by the cell, causing harm to the cell's mitochondria and eventually leading to cell death. Further elucidation of the mechanism of PAMAM cytotoxicity would help resolve the dispute as to precisely how toxic the dendrimers are.'
[0]https://en.wikipedia.org/wiki/Poly(amidoamine)#Toxicity https://en.wikipedia.org/wiki/Poly(amidoamine)#Toxicity
- gerbal 10y agoHave there been animal model tests of these particles?
- danielmorozoff 10y agoSeems so. Results are conflicting in terms of adverse effects. But seem to show these particles cross into normal cells (neurons for example)/ some lead to death some do not. here is a quote though from one paper in mice at high concentrations: 'There was no effect on other haematological parameters. Histopathological evaluation of dendrimer-treated groups did not reveal any abnormalities in the low- and medium-dose groups, but at a high dose level, toxicity was observed in the liver and kidney.' http://rspa.royalsocietypublishing.org/content/466/2117/1535 http://rspa.royalsocietypublishing.org/content/466/2117/1535 http://pubs.acs.org/doi/abs/10.1021/mp300391v http://pubs.acs.org/doi/abs/10.1021/mp300391v https://www.ncbi.nlm.nih.gov/pubmed/27534577 https://www.ncbi.nlm.nih.gov/pubmed/27534577